a bold conversations roundtable

Winning Enrollment in a Competitive CNS Trial Landscape

Many CNS trials today operate in a highly competitive environment marked by overlapping patient populations, strained sites, and saturated recruitment pathways. Enrollment success is shaped by the decisions teams make under these constraints.

This Bold Conversations roundtable brings together perspectives from investigative sites, sponsors, recruitment partners, and clinical operations to examine how sites prioritize studies, how sponsors plan for competition, and how operational and recruitment decisions affect enrollment momentum in competitive CNS trials.

Designed for sponsors navigating complex CNS programs, this roundtable delivers practical, forward-looking insights into how teams move from pressure to progress and build enrollment strategies that hold up in real world conditions.

TOPIC: Winning Enrollment in a Competitive CNS Trial Landscape
DATE & TIME: June 3, 2026 at 11:00 AM ET
DURATION: 55 Minutes
AVAILABILITY: 100 Seats
FORMAT: Expert Panel Discussion

voices you'll want to hear from

Meet the Panelists

Carl Gommoll, MS

Vice President & Head of Clinical Operations, Acadia Pharmaceuticals

Carl Gommoll brings more than 30 years of pharmaceutical industry experience to his role overseeing global clinical trial operations at Acadia Pharmaceuticals. His background spans senior leadership positions at AbbVie and BioXcel Therapeutics, where he led late-stage CNS and psychiatric programs through regulatory approval. He brings a practical, operations-driven perspective to enrollment strategy and sponsor execution in competitive trial environments.

Nicole Alleyne, MS

Clinical Program Manager, Supernus Pharmaceuticals

Nicole Alleyne is a clinical researcher with more than 15 years of experience across the pharmaceutical industry, with recent focus on CNS and a lead role in Supernus Pharmaceuticals' major depressive disorder program. Her background spans site-based roles in academia and the private sector, as well as experience at the FDA. She holds master's degrees in Physiology and Biophysics and Systems Medicine from Georgetown University.

Lance Nickens

Founder and President, TPRA - The Patient Recruiting Agency™

Lance Nickens has spent nearly three decades in patient recruitment and retention, founding TPRA as a specialized division in the late 1990s and acquiring it in 2004 to build it into one of the industry's most respected global agencies. He is widely credited with helping shape the modern patient recruitment industry, pioneering approaches and technologies that have since become standard practice across clinical research globally.

Jessica Sletten, MBA

Founder and Chief Operating Officer, Charter Research

Jessica Sletten is a nationally renowned clinical trials executive with more than 20 years of experience in clinical research site operations and site network management. Prior to founding Charter Research, she served as VP of Clinical Operations at Bioclinica and oversaw clinical operations at Compass Research, where she implemented strategies that propelled the company to become the #1 enroller in the world in Alzheimer's disease research.

Jim Free (Host)

Executive Vice President, Site Solutions, Cognitive Research Corporation

Jim Free has more than 20 years of experience building study site networks for clinical programs requiring specialized patient populations, with a focus on CNS indications including agitation in dementia, anxiety disorders, and treatment-resistant depression. Throughout his career he has served as a C-level executive across 11 companies and has firsthand experience overseeing IND, NDA, and ANDA submissions through approval and commercial launch.

Be Bold. Be Ready. Be Early.

Access Insights that Could Prevent Your Trial from Becoming a Cautionary Tale.

why it matters

Where Enrollment
Momentum Is Won or Lost

CNS trials today are competing for the same sites, the same patients, and the same recruitment channels at the same time. The decisions that determine your enrollment outcome are largely made before the study launches, from protocol design and site selection to feasibility assumptions and recruitment strategy. By the time problems surface, the window to course-correct has usually passed.

This roundtable brings together the people who see those decisions play out from every angle. What they share is directly applicable to how sponsors plan, execute, and recover in competitive CNS programs.

You’ll gain perspective on:

Optimizing protocol and operational strategy for site-level realities
How sites prioritize studies when patient populations overlap
What teams often misjudge in competitive enrollment planning
Where recruitment efforts succeed or stall in saturated populations
How operational decisions shape enrollment momentum
What successful teams do differently in crowded CNS trials
What sponsors should be planning for as competition intensifies

Winning Enrollment in a Competitive CNS Trial Landscape